TY  - GEN
AU  - Bae,S I
AU  - Cheriyath,V
AU  - Jacobs,B S
AU  - Reu,F J
AU  - Borden,E C
TI  - Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL
SN  - 1476-5594
PY  - 2008///0206
KW  - Apoptosis
KW  - drug effects
KW  - Azacitidine
KW  - analogs & derivatives
KW  - Cell Line, Tumor
KW  - DNA (Cytosine-5-)-Methyltransferase 1
KW  - DNA (Cytosine-5-)-Methyltransferases
KW  - antagonists & inhibitors
KW  - DNA Methylation
KW  - Decitabine
KW  - Drug Evaluation, Preclinical
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Gene Expression Regulation, Neoplastic
KW  - Gene Silencing
KW  - Humans
KW  - Interferons
KW  - therapeutic use
KW  - Melanoma
KW  - drug therapy
KW  - Receptors, TNF-Related Apoptosis-Inducing Ligand
KW  - genetics
KW  - TNF-Related Apoptosis-Inducing Ligand
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1038/sj.onc.1210655
ER  -